Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immune Checkpoint Inhibitor-Induced Vitiligo-Like Depigmentation.
Starace M, Cedirian S, Rapparini L, Pileri A, Carrera C, Giavedoni P, Alonso de Leon MT, Kraehenbuehl L, Elshot YS, Apalla Z, Papegeorgiou C, Nikolaou V, Radevic T, Lengyel Z, Sollena P, Peris K, Rossi E, Fattore D, Koumaki D, Boada A, Forsea AM, Segura S, Freites-Martinez A, Riganti J, Avitan-Hersh E, Saffuri N, Peuvrel L, Dezoteux F, Piraccini BM, Sibaud V. Starace M, et al. Among authors: kraehenbuehl l. JAMA Dermatol. 2024 Dec 23. doi: 10.1001/jamadermatol.2024.5136. Online ahead of print. JAMA Dermatol. 2024. PMID: 39714856
European recommendations for management of immune checkpoint inhibitors-derived dermatologic adverse events. The EADV task force 'Dermatology for cancer patients' position statement.
Apalla Z, Nikolaou V, Fattore D, Fabbrocini G, Freites-Martinez A, Sollena P, Lacouture M, Kraehenbuehl L, Stratigos A, Peris K, Lazaridou E, Richert B, Vigarios E, Riganti J, Baroudjian B, Filoni A, Dodiuk-Gad R, Lebbé C, Sibaud V. Apalla Z, et al. Among authors: kraehenbuehl l. J Eur Acad Dermatol Venereol. 2022 Mar;36(3):332-350. doi: 10.1111/jdv.17855. Epub 2021 Dec 15. J Eur Acad Dermatol Venereol. 2022. PMID: 34910332
Management of human epidermal growth factor receptor inhibitors-related acneiform rash: A position paper based on the first Europe/USA Delphi consensus process.
Apalla Z, Freites-Martinez A, Grafanaki K, Ortiz-Brugues A, Nikolaou V, Fattore D, Sollena P, Deverapalli S, Babakoohi S, Galimont A, Kluger N, Beylot-Barry M, Larocca C, Iriarte C, Smith J, Tattersall I, Dodiuk-Gad R, Sauder M, Carrera C, Kwong B, Whitley M, Leboeuf N, Romano P, Starace M, Mateeva V, Riganti J, Hirner J, Patel AB, Reyes-Habito CM, Kraehenbuehl L, Kheterpal M, Fida M, Hassel J, Lacouture M, Sibaud V. Apalla Z, et al. Among authors: kraehenbuehl l. J Eur Acad Dermatol Venereol. 2024 Oct 26. doi: 10.1111/jdv.20391. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 39460590
Real-World Data on Clinical Outcomes and Treatment Management of Advanced Melanoma Patients: Single-Center Study of a Tertiary Cancer Center in Switzerland.
Staeger R, Martínez-Gómez JM, Turko P, Ramelyte E, Kraehenbuehl L, Del Prete V, Hasan Ali O, Levesque MP, Dummer R, Nägeli MC, Mangana J. Staeger R, et al. Among authors: kraehenbuehl l. Cancers (Basel). 2024 Feb 20;16(5):854. doi: 10.3390/cancers16050854. Cancers (Basel). 2024. PMID: 38473216 Free PMC article.
Immunologic Profiling of Immune-Related Cutaneous Adverse Events with Checkpoint Inhibitors Reveals Polarized Actionable Pathways.
Lacouture ME, Goleva E, Shah N, Rotemberg V, Kraehenbuehl L, Ketosugbo KF, Merghoub T, Maier T, Bang A, Gu S, Salvador T, Moy AP, Lyubchenko T, Xiao O, Hall CF, Berdyshev E, Crooks J, Weight R, Kern JA, Leung DYM. Lacouture ME, et al. Among authors: kraehenbuehl l. Clin Cancer Res. 2024 Jul 1;30(13):2822-2834. doi: 10.1158/1078-0432.CCR-23-3431. Clin Cancer Res. 2024. PMID: 38652814 Free PMC article.
Immune-related cutaneous adverse events due to checkpoint inhibitors.
Wang E, Kraehenbuehl L, Ketosugbo K, Kern JA, Lacouture ME, Leung DYM. Wang E, et al. Among authors: kraehenbuehl l. Ann Allergy Asthma Immunol. 2021 Jun;126(6):613-622. doi: 10.1016/j.anai.2021.02.009. Epub 2021 Feb 17. Ann Allergy Asthma Immunol. 2021. PMID: 33609771 Free PMC article. Review.
Management of immune-related cutaneous adverse events with dupilumab.
Kuo AM, Gu S, Stoll J, Moy AP, Dusza SW, Gordon A, Haliasos EC, Janjigian Y, Kraehenbuehl L, Quigley EA, Chapman P, Lacouture ME, Markova A. Kuo AM, et al. Among authors: kraehenbuehl l. J Immunother Cancer. 2023 Jun;11(6):e007324. doi: 10.1136/jitc-2023-007324. J Immunother Cancer. 2023. PMID: 37270183 Free PMC article.
Our current understanding of checkpoint inhibitor therapy in cancer immunotherapy.
Goleva E, Lyubchenko T, Kraehenbuehl L, Lacouture ME, Leung DYM, Kern JA. Goleva E, et al. Among authors: kraehenbuehl l. Ann Allergy Asthma Immunol. 2021 Jun;126(6):630-638. doi: 10.1016/j.anai.2021.03.003. Epub 2021 Mar 11. Ann Allergy Asthma Immunol. 2021. PMID: 33716146 Free PMC article. Review.
41 results